Barclays maintains Overweight on Cencora, lowers price target to $350
Barclays analyst Glen Santangelo maintains an Overweight rating on Cencora but lowers the price target to $350 from $425, reflecting a revised valuation outlook.
*this image is generated using AI for illustrative purposes only.
Barclays analyst Glen Santangelo has maintained an Overweight rating on Cencora while lowering the price target to $350 from $425. The revised target suggests a shift in the stock's valuation expectations despite the continued positive stance.
Rating and Price Target Details
The decision to retain the Overweight rating indicates confidence in Cencora's performance relative to its sector peers. However, the reduction in the price target highlights a more conservative near-term outlook.
| Metric | Value |
|---|---|
| Rating | Overweight |
| Previous Price Target | $425 |
| New Price Target | $350 |
The adjustment comes as part of a routine review of the company's financial position and market conditions.
What specific market conditions prompted Barclays to adopt a more conservative near-term outlook?
How might this price target reduction influence investor sentiment toward Cencora in the coming weeks?
Could other analysts follow Barclays' lead in adjusting their price targets for Cencora?
20
Create Custom Screeners 
Access 200+ Pre-built Filters 
Use 50+ Readymade Screener 
